Filing Details
- Accession Number:
- 0001209191-13-006630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-05 19:08:41
- Reporting Period:
- 2013-02-05
- Filing Date:
- 2013-02-05
- Accepted Time:
- 2013-02-05 19:08:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949699 | Pharmacyclics Inc | PCYC | Pharmaceutical Preparations (2834) | 943148201 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383004 | J David Loury | C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085-4521 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-05 | 20,000 | $2.76 | 20,325 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-05 | 20,000 | $70.58 | 325 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy | Disposition | 2013-02-05 | 20,000 | $0.00 | 20,000 | $2.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,000 | 2007-03-13 | 2017-03-13 | No | 4 | M | Direct |
Footnotes
- Sale of shares poursuant to a 10b5-1 plan adopted on December 21, 2012.
- The option shares vest in a series of 48 equal and successive monthly installments measured from 3/13/2007.
Billionaire Hedge Funds
